相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline
Hedy L. Kindler et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase
Ryan Yudistiro et al.
MOLECULAR PHARMACEUTICS (2018)
Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma
Sukran Ulger et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2017)
Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model
Shinji Abe et al.
CANCER SCIENCE (2016)
Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamine
Nancy L. Oleinick et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Radioimmunotherapy of pancreatic cancer xenografts in nude mice using 90Y-labeled anti-α6β4 integrin antibody
Winn Aung et al.
ONCOTARGET (2016)
Evaluation of Efficacy of Radioimmunotherapy with 90Y- Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models
Aya Sugyo et al.
PLOS ONE (2015)
90Y-Labeled Anti-ROBO1 Monoclonal Antibody Exhibits Antitumor Activity against Small Cell Lung Cancer Xenografts
Kentaro Fujiwara et al.
PLOS ONE (2015)
Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients
Emanuela Taioli et al.
PLOS ONE (2015)
Radioimmunotherapy of human tumours
Steven M. Larson et al.
NATURE REVIEWS CANCER (2015)
Prognostic Value of Podoplanin Expression in Oral Squamous Cell Carcinoma-A Regression Model Auxiliary to UICC Classification
Sachiko Seki et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Radioimmunotherapy: A Specific Treatment Protocol for Cancer by Cytotoxic Radioisotopes Conjugated to Antibodies
Hidekazu Kawashima
TheScientificWorldJOURNAL (2014)
Repopulation of tumor cells during fractionated radiotherapy and detection methods (Review)
Jia Yang et al.
ONCOLOGY LETTERS (2014)
Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors
Vidyalakshmi Chandramohan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin Antibody
Shinji Abe et al.
JOURNAL OF IMMUNOLOGY (2013)
Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer
Chisato Yoshida et al.
PLOS ONE (2013)
Evaluation of 89Zr-Labeled Human Anti-CD147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer
Aya Sugyo et al.
PLOS ONE (2013)
Cancer and Radiation Therapy: Current Advances and Future Directions
Rajamanickam Baskar et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2012)
Podoplanin-Positive Fibroblasts Enhance Lung Adenocarcinoma Tumor Formation: Podoplanin in Fibroblast Functions for Tumor Progression
Ayuko Hoshino et al.
CANCER RESEARCH (2011)
Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals
Sibaprasad Bhattacharyya et al.
DALTON TRANSACTIONS (2011)
In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells
An Wouters et al.
BMC CANCER (2010)
C-kit-targeted imaging of gastrointestinal stromal tumor using radiolabeled anti-c-kit monoclonal antibody in a mouse tumor model
Chizuru Sogawa et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors
Jean-Francois Chatal et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2009)
Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis
Youya Nakazawa et al.
BLOOD (2008)
Therapeutic radionuclides: Biophysical and radiobiologic principles
Amin I. Kassis
SEMINARS IN NUCLEAR MEDICINE (2008)
Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain
Yukinari Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Overexpression of podoplanin in oral cancer and its association with poor clinical outcome
Ping Yuan et al.
CANCER (2006)
Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression
K Mishima et al.
ACTA NEUROPATHOLOGICA (2006)
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity
H Yaziji et al.
MODERN PATHOLOGY (2006)
Podoplanin:: A novel diagnostic immunohistochemical marker
NG Ordóñez
ADVANCES IN ANATOMIC PATHOLOGY (2006)
Medical progress - Advances in malignant mesothelioma
BWS Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma
DH Sterman et al.
RESPIROLOGY (2005)
Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors
V Schacht et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Characterization of human PA2.26 antigen (T1α-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas
E Martín-Villar et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Podoplanin as a marker for mesothelioma
N Kimura et al.
PATHOLOGY INTERNATIONAL (2005)
Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma
Y Kato et al.
TUMOR BIOLOGY (2005)
Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors
Y Kato et al.
ONCOGENE (2004)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Intensity-modulated radiation therapy: A novel approach to the management of malignant pleural mesothelioma
A Ahamad et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
TE Witzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemia and myeloproliferative disorders
M Weinmann et al.
RADIOTHERAPY AND ONCOLOGY (2001)
分享论文
